B-cell lymphoma refers to a type of non-Hodgkin lymphoma (NHL) that originates in the B lymphocytes, which are a type of white blood cell responsible for producing antibodies to fight infections. These lymphomas develop when the B cells undergo malignant transformation, leading to uncontrolled growth and proliferation of abnormal B cells. B-cell lymphomas are the most common subtype of non-Hodgkin lymphoma (NHL), accounting for approximately 85% of all cases.
B-cell lymphomas can vary significantly in terms of aggressiveness, with some types growing slowly and others being highly aggressive. They are typically classified into several subtypes, including follicular lymphoma, diffuse large B-cell lymphoma (DLBCL), and Burkitt lymphoma, among others.
B-cell lymphoma is a type of non-Hodgkin lymphoma (NHL) that affects the B-cells, a crucial part of the body’s immune system responsible for producing antibodies to fight infections. This disease can manifest in various forms, ranging from slow-growing (indolent) to fast-growing (aggressive) types.
While the exact cause of B-cell lymphoma is not always clear, several factors can increase the risk:
Environmental exposure: Contact with certain chemicals, such as pesticides or herbicides, may also elevate the risk.
B-cell lymphoma includes various subtypes, each with distinct characteristics. The most common types include:
Symptoms of B-cell lymphoma can vary depending on the subtype but often include:
If you experience any of these symptoms, it’s important to seek medical attention for a proper diagnosis.
Accurate diagnosis is essential to determine the specific type of lymphoma and plan the most effective treatment. Dr. Rahul Bhargava uses the following diagnostic methods:
Treatment for B-cell lymphoma varies depending on the type, stage, and overall health of the patient. Dr. Rahul Bhargava offers personalized treatment plans, which may include:
The cost of B-cell lymphoma treatment in India is much more affordable compared to many Western countries, making it a popular choice for medical tourism. The total cost of treatment, including hospital stay and additional care, can vary depending on the type of lymphoma, treatment options, and the duration of care. Here’s an overview of the costs:
Initial Consultation:
USD: $30 – $100
INR: ₹2,200 – ₹7,400
Biopsy and Blood Tests:
USD: $50 – $200
INR: ₹3,700 – ₹14,800
Chemotherapy (per cycle):
USD: $400 – $2,700
INR: ₹30,000 – ₹2,00,000
Immunotherapy (per month):
USD: $1,000 – $5,000
INR: ₹75,000 – ₹3,75,000
Targeted Therapy (per month):
USD: $1,200 – $6,000
INR: ₹90,000 – ₹4,50,000
Radiation Therapy (full course):
USD: $600 – $2,000
INR: ₹50,000 – ₹1,50,000
Bone Marrow Transplant (Stem Cell Transplant):
USD: $15,000 – $30,000
INR: ₹12,00,000 – ₹24,00,000
Hospital Stay (per night):
USD: $25 – $200
INR: ₹2,000 – ₹15,000
India offers affordable and high-quality healthcare services, providing a cost-effective solution for patients seeking treatment for B-cell lymphoma. With world-class medical care and advanced treatment options, India remains a top destination for lymphoma treatment, while still being significantly more affordable than in Western countries.